• Sustainable Development
  • Recruitment
  • Natural health
  • Terms of use
  • Contact
  • Email
Email
  • e
  • v
logo
  • About Traphaco
    Stories of Traphaco

    Discover about Traphaco -  the top leading pharmaceutical company in Vietnam.

    See more ≫
    • History
    • Vision, mission, core values
    • Steering committee
    • Subsidiaries
    • Trophies, awards
    • Corporate Culture
  • News
    News

    Latest news about our products, activities and tips for happiness, health and a better life

    See more ≫
    • News
    • Customers with Traphaco
    • Press with Traphaco
    • Natural health
    • Traphaco Hung Yen Co., Ltd
    • Photo library
  • Products
    Products

    View product list ≫
    • Pharmaceuticals
      • Brain supplements
      • Disease prevention products
      • Eye medicine
      • Acide amine - vitamins and minerals
      • Sedative
      • Herbal supplements
      • Anti-inflammatory drugs yeast
      • Drugs mouth-nose-throat
      • Drugs used in eye
      • Analgesics - Anti-inflammatory
      • Topical treatment
      • Antihistamines
      • Parasitic drugs
      • Antifungals
      • Antibiotics
      • Antiviral drugs
      • Gynecological medicine
      • Insecticide
      • Cardiovascular medicines - Circulatory
      • Gastrointestinal drugs
      • Immune supplements and antioxidants
      • Osteoarthritis Drugs
      • Respiratory drugs
    • Supplements
    • Cosmetics
    • Imports
    • Medical supplies
    • Materials
  • Distribution
    Distribution

    Distribution ≫
    • Domestic Distribution
    • Overseas Distribution
  • Shareholder
    Shareholders

    View details ≫
    • Annual Reports
    • Financial Reports
    • General Meeting of Shareholders
    • Publishing News
    • Governance Report
    • Corporate
    • Governance Rules
    • Prospectus
  • Prevention of COVID-19
    Disease Prevention Covid-19

    • Products
    • News
  • Annual Reports
  • Financial Reports
  • General Meeting of Shareholders
  • Publishing News
  • Governance Report
  • Corporate
  • Governance Rules
  • Prospectus
Consolidated financial statement, quarter 3, 2022
Oct 25, 2022
Consolidated financial statement, quarter 3, 2022
  • Separate financial statement, quarter 3, 2022
    Oct 25, 2022
    Separate financial statement, quarter 3, 2022
  • Consolidated financial statements Q1/2022
    Apr 28, 2022
    Consolidated financial statements Q1/2022
  • Separate financial statements Q1/2022
    Apr 28, 2022
    Separate financial statements Q1/2022
  • Quarterly consolidated financial statements, For the nine-month period ended 30 September 2021
    Oct 22, 2021
    Quarterly consolidated financial statements, For the nine-month period ended 30 September 2021
  • Quarterly separate financial statements, For the nine-month period ended 30 September 2021
    Oct 22, 2021
    Quarterly separate financial statements, For the nine-month period ended 30 September 2021
  • Interim separate financial statements for the six-month period ender 30 June 2021
    Aug 27, 2021
    Interim separate financial statements for the six-month period ender 30 June 2021
  • Interim consolidated financial statements for the six-month period ender 30 June 2021
    Aug 27, 2021
    Interim consolidated financial statements for the six-month period ender 30 June 2021
  • Separate financial statements Q1/2021
    Apr 22, 2021
    Separate financial statements Q1/2021
  • Consolidated financial statements Q1/2021
    Apr 22, 2021
    Consolidated financial statements Q1/2021
  • 2019  Stand alone financial statements
    Mar 03, 2020
    2019 Stand alone financial statements
  • 2019 Consolidated Financial Report
    Mar 03, 2020
    2019 Consolidated Financial Report
  • Consolidated financial statements 2016
    Mar 13, 2017
    Consolidated financial statements 2016
  • 1
  • 2
  • >>
Latest Posts
Jan 30, 2023
Jan 30, 2023
Report on Corporate Governance, the year 2022
Jan 30, 2023
Report on Corporate Governance, the year 2022
Oct 31, 2022
Consolidated financial statement, quarter 3, 2022
Oct 25, 2022
Consolidated financial statement, quarter 3, 2022
Popular posts
Oct 06, 2016
Oct 06, 2016
Oct 06, 2016
Traphaco annual report 2013
Dec 30, 2013
Traphaco annual report 2013
Aug 04, 2016
Enterprise
  • History
  • Vision, mission
  • Core values
  • Steering committee
  • Subsidiaries
  • Trophies, awards
Products
  • Pharmaceuticals
  • Supplements
  • Cosmetics
  • Imports
  • Materials
  • Medical supplies
Natural health
  • Stay Happy Stay Healthy
  • Common Diseases
  • Precious Medicinal Plants
  • Health FAQ
Website links
  • Boganic
  • Cebraton
  • Tottri
  • Methorphan
Quality certification
  • verify
  • verify
  • verify
Traphaco Joint stock company

Headquarters: 75 Yen Ninh, Ba Dinh District, Hanoi, Vietnam | Trading Address: 15 Alley, Ngoi Hoi Lane, Hoang Liet Ward, Hoang Mai District, Hanoi

ĐT: 18006612 - Fax: (024) 36814910 | E-mail: info@traphaco.com.vn

Copyright © 2013 - 2023 Traphaco Company. Website designed by RIO Creative